NasdaqGS - Nasdaq Real Time Price ? USD Outset Medical, Inc. (OM) Follow Compare 0.5440 -0.0028 (-0.51%) At close: October 25 at 4:00 PM EDT 0.5549 +0.01 (+2.00%) After hours: October 25 at 7:57 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo Outset Medical features patient experience posterpresentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced two new research posters that demonstrate significant quality of life and menta GlobeNewswire ? 3 days ago OM -0.51% Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, November 6, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chie GlobeNewswire ? 3 days ago OM -0.51% Morgan Stanley's Strategic Reduction in Outset Medical Inc Shares On August 30, 2024, Morgan Stanley executed a significant transaction involving Outset Medical Inc (NASDAQ:OM), a company known for its innovative medical technology. This move reflects a strategic adjustment in Morgan Stanley's investment portfolio, despite the trade having a minimal immediate impact on its overall composition. Morgan Stanley, established in 1935, has evolved into a global financial services powerhouse with a presence in 42 countries. GuruFocus.com ? last month OM -0.51% MS-PQ JPMorgan Chase & Co's Strategic Reduction in Outset Medical Inc On August 30, 2024, JPMorgan Chase & Co executed a significant transaction involving Outset Medical Inc (NASDAQ:OM), a player in the medical technology sector. This move has adjusted the firm's portfolio, reflecting a strategic shift in its investment stance towards Outset Medical Inc. JPMorgan Chase & Co, with a storied history dating back to 1799, stands today as a global financial behemoth with operations in over 60 countries. GuruFocus.com ? last month OM -0.51% JPM The Consensus EPS Estimates For Outset Medical, Inc. (NASDAQ:OM) Just Fell Dramatically One thing we could say about the analysts on Outset Medical, Inc. ( NASDAQ:OM ) - they aren't optimistic, having just... Simply Wall St. ? 2 months ago OM -0.51% Outset Medical, Inc. (NASDAQ:OM) Just Reported And Analysts Have Been Cutting Their Estimates As you might know, Outset Medical, Inc. ( NASDAQ:OM ) last week released its latest second-quarter, and things did not... Simply Wall St. ? 2 months ago OM -0.51% Outset Medical Second Quarter 2024 Earnings: Misses Expectations Outset Medical ( NASDAQ:OM ) Second Quarter 2024 Results Key Financial Results Revenue: US$27.4m (down 24% from 2Q... Simply Wall St. ? 2 months ago OM -0.51% Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates Outset Medical (OM) delivered earnings and revenue surprises of -9.30% and 12.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago OM -0.51% Outset Medical Reports Second Quarter 2024 Financial Results SAN JOSE, Calif., August 07, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the second quarter ended June 30, 2024. Business Wire ? 2 months ago OM -0.51% 10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release 10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 2 months ago TXG OM -0.51% Will Outset Medical, Inc. (OM) Report Negative Earnings Next Week? What You Should Know Outset Medical (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 2 months ago OM -0.51% Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 SAN JOSE, Calif., July 24, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on Wednesday, August 7, 2024. Business Wire ? 3 months ago OM -0.51% 3 MedTech Stocks to Buy for Healthy Gains Fundamentally, few sectors exist outside of the broad healthcare umbrella that offer what I would term permanent relevance. In this case, the concept of caring for other people is likely an eternal one. So, it makes sense to consider medical technology or MedTech stocks to buy. As you know, the innovation ecosystem constantly moves in one direction: forward. It seems like every day, someone is talking about artificial intelligence or automated robotics or some invention in the connectivity arena InvestorPlace ? 3 months ago INMD ABT OM -0.51% Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock? Outset Medical (OM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Zacks ? 4 months ago OM -0.51% Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference SAN JOSE, Calif., June 03, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 45th annual Healthcare conference on Wednesday, June 12, 2024, at 11:20 a.m. Eastern time. Business Wire ? 4 months ago OM -0.51% Analysts Are Updating Their Outset Medical, Inc. (NASDAQ:OM) Estimates After Its First-Quarter Results It's shaping up to be a tough period for Outset Medical, Inc. ( NASDAQ:OM ), which a week ago released some... Simply Wall St. ? 5 months ago OM -0.51% Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses Financial Performance and Strategic Insights Amidst Market Challenges GuruFocus.com ? 5 months ago OM -0.51% Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript May 8, 2024 Outset Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the Outset Medical Q1 2024 Earnings Conference […] Insider Monkey ? 5 months ago OM -0.51% Q1 2024 Outset Medical Inc Earnings Call Q1 2024 Outset Medical Inc Earnings Call Thomson Reuters StreetEvents ? 5 months ago OM -0.51% Outset Medical First Quarter 2024 Earnings: US$0.79 loss per share (vs US$0.90 loss in 1Q 2023) Outset Medical ( NASDAQ:OM ) First Quarter 2024 Results Key Financial Results Revenue: US$28.2m (down 16% from 1Q... Simply Wall St. ? 5 months ago OM -0.51% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return OM S&P 500 YTD -89.94% +21.77% 1-Year -84.16% +36.74% 3-Year -98.94% +27.79%
